share_log

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports First Quarter 2023 Financial Results and Provides Clinical Program Updates

SEC ·  May 8, 2023 16:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more